Necrotic enteritis is a severe and economically devastating bacterial disease of poultry caused by Clostridium perfringens, an anaerobic, spore-forming bacterium that produces potent toxins affecting the intestinal tract. This condition represents one of the most significant health challenges facing the global poultry industry, with annual economic losses estimated at several billion dollars when accounting for mortality, reduced performance, increased medication costs, and carcass condemnations. The disease can manifest as acute clinical outbreaks with sudden high mortality or as a subclinical condition causing insidious production losses that may go unrecognized without careful monitoring.
Necrotic enteritis primarily affects young broiler chickens between two and six weeks of age, though it can occur in other poultry types including turkeys, layer pullets, and breeding stock. The disease has become increasingly prominent in recent years as the poultry industry transitions away from routine antibiotic use in feed, removing the prophylactic protection that ionophores and antimicrobial growth promoters previously provided against Clostridium perfringens overgrowth. This shift toward antibiotic-free production has necessitated renewed focus on understanding and preventing necrotic enteritis through alternative means.
The economic impact of necrotic enteritis extends far beyond direct mortality costs. Subclinical infections reduce feed efficiency, impair growth rates, and increase flock uniformity problems without obvious clinical signs. At processing, affected carcasses may be condemned due to liver lesions and intestinal damage, directly reducing revenue. The welfare implications are also significant, as birds experiencing intestinal necrosis and toxemia suffer considerable pain and distress. The contagious nature of the causative organism means that once established in a facility, Clostridium perfringens spores can persist for extended periods, creating ongoing challenges for disease management.
Necrotic enteritis is treatable when detected early, with several antibiotic options providing effective therapy in acute outbreaks. However, the reliance on treatment contradicts industry goals for reduced antibiotic use, making prevention the preferred approach. Understanding the complex predisposing factors that allow Clostridium perfringens to cause disease is essential for developing effective prevention programs. These factors include coccidiosis, dietary composition, and management practices that affect intestinal health and microbiome composition.
